EUVIMEDEUVIMED entdecken
Systematische ÜbersichtUmbrella ReviewOpen Access · CC BY-NC 4.0

Issues, Challenges and Opportunities for Economic Evaluations of Orphan Drugs in Rare Diseases: An Umbrella Review

Tobias Sydendal Grand iD, Shijie Ren iD, James Hall iD, Daniel Oudin Åström iD, Stephane Regnier iD, Praveen Thokala iD

PharmacoEconomics · 2024-06 · 42 (6) · 619-631

DOI: 10.1007/s40273-024-01370-2 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift PharmacoEconomics, online erschienen am 14.04.2024. Verfasst von Tobias Sydendal Grand und 5 weiteren Autor:innen. Beteiligte Einrichtung: Sheffield Centre for Health and Related Research (SCHARR), University of Sheffield, 30 Regent Street, Sheffield, S1 4DA, UK. tsgrand1@sheffield.ac.uk. Hauptthemen laut MEDLINE: Rare Diseases, Orphan Drug Production, Cost-Benefit Analysis, Technology Assessment, Biomedical. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Innovationsfonden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rare DiseasesOrphan Drug ProductionCost-Benefit AnalysisTechnology Assessment, BiomedicalHumansModels, Economic

Autor:innen und Institutionen

  • Sheffield Centre for Health and Related Research (SCHARR), University of Sheffield, 30 Regent Street, Sheffield, S1 4DA, UK. tsgrand1@sheffield.ac.uk.
  • Lundbeck A/S, Copenhagen, Denmark. tsgrand1@sheffield.ac.uk.
  • Sheffield Centre for Health and Related Research (SCHARR), University of Sheffield, 30 Regent Street, Sheffield, S1 4DA, UK.
  • Institute of Applied Health Research, Health Economics Unit, University of Birmingham, Edgbaston, Birmingham, UK.
  • Lundbeck A/S, Copenhagen, Denmark.

ORCID-Profile: Tobias Sydendal Grand, Shijie Ren, James Hall, Daniel Oudin Åström, Stephane Regnier, Praveen Thokala

Förderung

  • Innovationsfonden

Zitieren

APA

Grand, T. S., Ren, S., Hall, J., Åström, D. O., Regnier, S., & Thokala, P. (2024). Issues, Challenges and Opportunities for Economic Evaluations of Orphan Drugs in Rare Diseases: An Umbrella Review. PharmacoEconomics, 42(6), 619-631. https://doi.org/10.1007/s40273-024-01370-2

Vancouver

Grand TS, Ren S, Hall J, Åström DO, Regnier S, Thokala P. Issues, Challenges and Opportunities for Economic Evaluations of Orphan Drugs in Rare Diseases: An Umbrella Review. PharmacoEconomics. 2024;42(6):619-631. doi:10.1007/s40273-024-01370-2

BibTeX
@article{Grand2024,
  author = {Grand, Tobias Sydendal and Ren, Shijie and Hall, James and Åström, Daniel Oudin and Regnier, Stephane and Thokala, Praveen},
  title = {Issues, Challenges and Opportunities for Economic Evaluations of Orphan Drugs in Rare Diseases: An Umbrella Review},
  journal = {PharmacoEconomics},
  year = {2024},
  volume = {42},
  number = {6},
  pages = {619--631},
  doi = {10.1007/s40273-024-01370-2}
}
Kostenlos starten →